Disease Info Card

Lecithin Acyltransferase Deficiency

Information about Lecithin Acyltransferase Deficiency: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Lecithin Acyltransferase Deficiency

Most recent studies have shown that Lecithin Acyltransferase Deficiency shares some biological mechanisms with anemia, anemia-hemolytic, arteriosclerosis, atherosclerosis, cardiovascular-diseases, corneal-diseases, disorder-of-eye, dyslipidemias, fish-eye-disease, hereditary-diseases, hyperlipidemia, hyperlipoproteinemias, hypolipoproteinemias, inborn-errors-of-metabolism, kidney-diseases, kidney-failure, kidney-failure-chronic, liver-diseases, proteinuria-of-undiagnosed-cause, tangier-disease.

Among the many pathways, these few ones have gauged particular interests from scientists studying Lecithin Acyltransferase Deficiency, and have been seen in publications frequently: Chemotaxis, Cholesterol Efflux, Cholesterol Esterification, Cholesterol Homeostasis, Cholesterol Transport, Excretion, Glycosylation, Intestinal Cholesterol Absorption, Lipid Binding, Lipid Transport, Localization, Monocyte Chemotaxis, Pathogenesis, Platelet Aggregation, Reflex, Reverse Cholesterol Transport, Secretion, Translation, Transport, Wound Healing

Quite a number of genes have been found to play important roles in Lecithin Acyltransferase Deficiency, such as ABCA1, ALB, APOA1, APOA2, APOB, APOE, CETP, INS, LCAT, LDLR, LIPC, LPA, LPL, QPCT, SOAT2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.